<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://biomedcentral.com/feeds/latestarticles/journal?journal=bmcpregnancychildbirth&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Pregnancy and Childbirth - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpregnancychildbirth/</link>
        <description>The latest research articles published by BMC Pregnancy and Childbirth</description>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/114" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/113" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/112" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/111" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/110" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/109" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/108" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/107" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/106" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/13/105" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/114">
        <title>Significant others, situations and infant feeding behaviour change processes: a serial qualitative interview study</title>
        <description>Background:
Exclusive breastfeeding until six months followed by the introduction of solids and continued breastfeeding is recommended by the World Health Organisation. The dominant approach to achieving this has been to educate and support women to start and continue breastfeeding rather than understanding behaviour change processes from a broader perspective.MethodSerial qualitative interviews examined the influences of significant others on women&apos;s feeding behaviour. Thirty-six women and 37 nominated significant others participated in 220 interviews, conducted approximately four weekly from late pregnancy to six months after birth. Responses to summative structured questions at the end of each interview asking about significant influences on feeding decisions were compared and contrasted with formative semi-structured data within and between cases. Analysis focused on pivotal points where behaviour changed from exclusive breastfeeding to introducing formula, stopping breastfeeding or introducing solids. This enabled us to identify processes that decelerate or accelerate behaviour change and understand resolution processes afterwards.
Results:
The dominant goal motivating behaviour change was family wellbeing, rather than exclusive breastfeeding. Rather than one type of significant other emerging as the key influence, there was a complex interplay between the self-baby dyad, significant others, situations and personal or vicarious feeding history. Following behaviour change women turned to those most likely to confirm or resolve their decisions and maintain their confidence as mothers.
Conclusions:
Applying ecological models of behaviour would enable health service organisation, practice, policy and research to focus on enhancing family efficacy and wellbeing, improving family-centred communication and increasing opportunities for health professionals to be a constructive influence around pivotal points when feeding behaviour changes. A paradigm shift is recommended away from the dominant approach of support and education of individual women towards a more holistic, family-centred narrative approach, whilst acknowledging that breastfeeding is a practical skill that women and babies have to learn.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/114</link>
                <dc:creator>Rhona McInnes</dc:creator>
                <dc:creator>Pat Hoddinott</dc:creator>
                <dc:creator>Jane Britten</dc:creator>
                <dc:creator>Kirsty Darwent</dc:creator>
                <dc:creator>Leone Craig</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:114</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-114</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-114-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>114</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/113">
        <title>Habitual snoring and depressive symptoms during pregnancy</title>
        <description>Background:
Depression is frequently observed in patients with untreated sleep-disordered breathing (SDB) in the general population. Pregnant women are particularly vulnerable since pregnancy increases the risk of both SDB and depressive symptoms. However, no study has investigated whether SDB symptoms prior to or in early pregnancy are associated with such mood problems.
Methods:
A retrospective chart review of pregnant women. Women were included if they attended prenatal clinics between June 2007 and July 2010, were &gt;=18 years old, pregnant with a single fetus, and had been screened for habitual snoring as well as depressive symptoms using the Edinburgh Postnatal Depression Scales (EPDS).
Results:
In total, 362 women were included and 32.3% reported habitual snoring. Twenty-nine percent of women had an EPDS score &gt;=10. Significantly more snoring women, compared to non-snorers, had an EPDS score &gt;=10 (42.7% vs. 22.9%, p &lt; 0.001) despite the mean EPDS values not reaching statistical significance (6.1 +/- 4.9 vs. 5.4 +/- 5.0, p = 0.2). In a logistic regression model controlling for parity, the presence of pre-pregnancy obesity, presence of a partner, sleep quality, African American race, maternal educational level, pre-eclampsia, and diabetes, snoring was independently associated with a prenatal EPDS score &gt;=10 (O.R. 2.0, 95%CI 1.13-3.46; p = 0.023).
Conclusion:
Maternal snoring may be a risk factor for prenatal depressive symptoms. Further investigation of the temporal relationship between maternal snoring and depressive symptoms is warranted.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/113</link>
                <dc:creator>Louise O¿Brien</dc:creator>
                <dc:creator>Jocelynn Owusu</dc:creator>
                <dc:creator>Leslie Swanson</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:113</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-113</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-113-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>113</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/112">
        <title>Measuring the risk factors for postpartum depression: development of the Japanese version of the Postpartum Depression Predictors Inventory-Revised (PDPI-R-J)</title>
        <description>Background:
Postpartum depression (PPD) is a global phenomenon. Depression in the first month following delivery is experienced by 20% of mothers in Japan. Therefore, a screening instrument that identifies the risk for depression during pregnancy and in the early postpartum period is required for primary prevention. The aims of this study were to develop the Japanese version of the Postpartum Depression Predictors Inventory-Revised (PDPI-R-J) and determine its predictive validity during pregnancy and one month after delivery.
Methods:
In order to develop the inventory, two bilingual translators translated the PDPI-R into Japanese. Then, back translation was done and a thorough discussion with the original developer was conducted in order to establish semantic equivalence. After the PDPI-R-J was developed, the study used a prospective cohort design. A total of 84 women in their eighth month of pregnancy participated in the study. Seventy-six mothers completed the PDPI-R-J at the first month after childbirth. Women were diagnosed using Mini-International Neuropsychiatric Interview (M.I.N.I.) to determine the presence of minor or major depression at the first month after childbirth and the receiver operating characteristic curve was plotted to evaluate the predictive capacity of PDPI-R-J.
Results:
Of the 76 mothers who completed the PDPI-R-J during the first-month assessment, 16 mothers (21%) met the PPD criteria. The prenatal version of the PDPI-R-J administered during pregnancy accurately predicted 62.8% of PPD (95% CI 0.48--0.77) and the postpartum version administered at the first month after delivery predicted 82.0% of PPD (95% CI 0.71--0.93). The cutoffs identified were 5.5 for the prenatal version and 7.5 for the postpartum version. The PDPI-R-J postpartum version, which includes items relating to the infant, increased the predictive validity of PPD (0.67 to 0.82). Comments from the participants included that the use of the PDPI-R-J enhanced the chance to openly communicate about their history and risks for depression with the researchers, if any existed.
Conclusions:
The PDPI-R-J was found to be a useful and valid screening tool for predicting PPD. Both the prenatal and postpartum versions should be continuously administered to mothers because delivery and infant-related factors affect the potential for PPD.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/112</link>
                <dc:creator>Mari Ikeda</dc:creator>
                <dc:creator>Kiyoko Kamibeppu</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:112</dc:source>
        <dc:date>2013-05-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-112</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-112-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>112</prism:startingPage>
        <prism:publicationDate>2013-05-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/111">
        <title>&quot;Struggling with daily life and enduring pain&quot;: A qualitative study of the experiences of pregnant women living with pelvic girdle pain</title>
        <description>Background:
Few studies have investigated the experiences of living with pelvic girdle pain (PGP) and its impact on pregnant women&apos;s lives. To address this gap in knowledge, this study investigates the experiences of women living with PGP during pregnancy.
Methods:
A purposive sample, of nine pregnant women with diagnosed PGP, were interviewed about their experiences. Interviews were recorded, transcribed to text and analysed using a Grounded Theory approach.
Results:
The core category that evolved from the analysis of experiences of living with PGP in pregnancy was &quot;struggling with daily life and enduring pain&quot;. Three properties addressing the actions caused by PGP were identified: i) grasping the incomprehensible; ii) balancing support and dependence and iii) managing the losses. These experiences expressed by the informants constitute a basis for the consequences of PGP: iv) enduring pain; v) being a burden; vi) calculating the risks and the experiences of the informants as vii) abdicating as a mother. Finally, the informants&apos; experiences of the consequences regarding the current pregnancy and any potential future pregnancies is presented in viii) paying the price and reconsidering the future. A conceptual model of the actions and consequences experienced by the pregnant informants living with PGP is presented.
Conclusions:
PGP during pregnancy greatly affects the informant&apos;s experiences of her pregnancy, her roles in relationships, and her social context. For informants with young children, PGP negatively affects the role of being a mother, a situation that further strains the experience. As the constant pain disturbs most aspects of the lives of the informants, improvements in the treatment of PGP is of importance as to increase the quality of life. This pregnancy-related condition is prevalent and must be considered a major public health concern during pregnancy.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/111</link>
                <dc:creator>Margareta Persson</dc:creator>
                <dc:creator>Anna Winkvist</dc:creator>
                <dc:creator>Lars Dahlgren</dc:creator>
                <dc:creator>Ingrid Mogren</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:111</dc:source>
        <dc:date>2013-05-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-111</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-111-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>111</prism:startingPage>
        <prism:publicationDate>2013-05-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/110">
        <title>Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort</title>
        <description>Background:
To evaluate the soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio for the prediction of early- and late-onset preeclampsia in a high-risk cohort.
Methods:
We studied serial serum samples collected prospectively at 12 + 0 - 14 + 0, 18 + 0 - 20 + 0, and 26 + 0 - 28 + 0 weeks + days of gestation in 6 women who developed early-onset preeclampsia (before 34 weeks of gestation) and in 21 women who developed late-onset preeclampsia (after 34 weeks of gestation) with automated ElecSys 2010 immunoanalyzer (Roche Diagnostics, Germany). Twenty-six high-risk women and 53 women without risk factors with normal pregnancies served as controls.
Results:
Serum PlGF concentrations were lower at 18 + 0 to 20 + 0, and 26 + 0 to 28 + 0 weeks of gestation in women who developed early-onset preeclampsia compared to women who developed late-onset preeclampsia and to controls (p &lt; 0.05 for all comparisons). At 18 + 0 to 20 + 0 weeks of gestation area under the receiver-operating characteristic curve (AUC) for serum PlGF was 99.8% (p = 0.0007, 95%CI 99.0-100.0). At 26 + 0 to 28 + 0 weeks of gestation serum sFlt-1/PlGF ratio explicitly detects those women who developed early-onset preeclampsia (AUC 100.0%, p = 0.0007, 95%CI 100--100). Amongst women with late-onset preeclampsia, those who developed severe form of the disease (N = 8) had significantly higher serum sFlt-1 concentrations at all three timepoints (p = 0.004, p = 0.006, and p = 0.003, respectively) compared to women with non-severe form (N = 13).
Conclusions:
Low serum PlGF concentration predicts early-onset preeclampsia from the second trimester and elevated serum sFlt-1/PlGF ratio from 26 to 28 weeks of gestation. Elevated serum sFlt-1 concentration in the first trimester in women who later develop late-onset, severe preeclampsia may suggest different etiology compared to the late-onset non-severe form of the disease.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/110</link>
                <dc:creator>Pia Villa</dc:creator>
                <dc:creator>Esa Hämäläinen</dc:creator>
                <dc:creator>Annukka Mäki</dc:creator>
                <dc:creator>Katri Räikkönen</dc:creator>
                <dc:creator>Anu-Katriina Pesonen</dc:creator>
                <dc:creator>Pekka Taipale</dc:creator>
                <dc:creator>Eero Kajantie</dc:creator>
                <dc:creator>Hannele Laivuori</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:110</dc:source>
        <dc:date>2013-05-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-110</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-110-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>110</prism:startingPage>
        <prism:publicationDate>2013-05-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/109">
        <title>Effects of a ketogenic diet during pregnancy on embryonic growth in the mouse</title>
        <description>Background The increasing use of the ketogenic diet (KD),particularly by women of child-bearing age, raises a question aboutits suitability during gestation. To date, no studies have thoroughlyinvestigated the direct implications of a gestational ketogenic dieton embryonic development.Methods To fill this knowledge gap we CD-1 mouse embryos whose mothers were fed either aStandard Diet (SD) or a KD 30 days prior to, as well as during gestation.Images were collected at embryonic days (E) 13.5 using Optical ProjectionTomography (OPT) and at E17.5 using Magnetic Resonance Imaging (MRI).Results An anatomical comparison of the SD and KD embryosrevealed that at E13.5 the average KD embryo was volumetrically larger,possessed a relatively larger heart but smaller brain, and had a smallerpharynx, cervical spinal cord, hypothalamus, midbrain, and pons, comparedwith the average SD embryo. At E17.5 the KD embryo was found to bevolumetrically smaller with a relatively smaller heart and thymus,but with enlarged cervical spine, thalamus, midbrain and pons.Conclusion A ketogenic diet during gestation results in alterations in embryonicorgan growth. Such alterations may be associated with organ dysfunctionand potentially behavioral changes in postnatal life.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/109</link>
                <dc:creator>Dafna Sussman</dc:creator>
                <dc:creator>Matthijs van Eede</dc:creator>
                <dc:creator>Michael Wong</dc:creator>
                <dc:creator>Susan Adamson</dc:creator>
                <dc:creator>Mark Henkelman</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:109</dc:source>
        <dc:date>2013-05-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-109</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-109-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>109</prism:startingPage>
        <prism:publicationDate>2013-05-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/108">
        <title>Measures of satisfaction with care during labour and birth: a comparative review</title>
        <description>Background:
Satisfaction is the one of the most frequently reported outcome measures for quality of care. Assessment of satisfaction with maternity services is crucial, and psychometrically sound measures are needed if this is to inform health practices. This paper comparatively reviews current measures of satisfaction with care during labour and birth.
Methods:
A review of the literature was conducted. Studies were located through computerised databases and hand searching references of identified articles and reviews. Inclusion criteria were that the questionnaire was a multi-item scale of satisfaction with care during labour and birth, and some form of psychometric information (either information about questionnaire construction, or reliability, or validity) had to be reported.
Results:
Nine questionnaires of satisfaction with care during labour and birth were identified. Instruments varied in psychometric properties and dimensions. Most described questionnaire construction and tested some form of reliability and validity. Measures were generally not based on the main theoretical models of satisfaction and varied in scope and application to different types of samples (e.g. satisfaction following caesarean section). For an in-depth measure of satisfaction with intrapartum care, the Intrapartal-Specific Quality from the Patient&apos;s Perspective questionnaire (QPP-I) is recommended. Brief measures with good reliability and validity are provided by the Six Simple Questions (SSQ) or Perceptions of Care Adjective Checklist (PCACL-R).
Conclusions:
Despite the interest in measures of satisfaction there are only a small number of validated measures of satisfaction with care during labour and birth. It is important that brief, reliable and valid measures are available for use in general and specific populations in order to assist research and inform practice.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/108</link>
                <dc:creator>Alexandra Sawyer</dc:creator>
                <dc:creator>Susan Ayers</dc:creator>
                <dc:creator>Jane Abbott</dc:creator>
                <dc:creator>Gillian Gyte</dc:creator>
                <dc:creator>Heike Rabe</dc:creator>
                <dc:creator>Lelia Duley</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:108</dc:source>
        <dc:date>2013-05-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-108</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-108-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>108</prism:startingPage>
        <prism:publicationDate>2013-05-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/107">
        <title>Increasing caesarean section rates among low-risk groups: a panel study classifying deliveries according to Robson at a university hospital in Tanzania</title>
        <description>Background:
Rising caesarean section (CS) rates have been observed worldwide in recent decades. This study sought to analyse trends in CS rates and outcomes among a variety of obstetric groups at a university hospital in a low-income country.
Methods:
We conducted a hospital-based panel study at Muhimbili National Hospital, Dar es Salaam, Tanzania. All deliveries between 2000 and 2011 with gestational age&#8201;&#8805;&#8201;28 weeks were included in the study. The 12 years were divided into four periods: 2000 to 2002, 2003 to 2005, 2006 to 2008, and 2009 to 2011. Main outcome measures included CS rate, relative size of obstetric groups, contribution to overall CS rate, perinatal mortality ratio, neonatal distress, and maternal mortality ratio. Time trends were analysed within the ten Robson groups, based on maternal and obstetric characteristics. We applied the &#967;
						2 test for trend to determine whether changes were statistically significant. Odds ratios of CS were evaluated using multivariate logistic regression, accounting for maternal age, referral status, and private healthcare insurance.
Results:
We included 137,094 deliveries. The total CS rate rose from 19% to 49%, involving nine out of ten groups. Multipara without previous CS with single, cephalic pregnancies in spontaneous labour had a CS rate of 33% in 2009 to 2011. Adjusted analysis explained some of the increase. Perinatal mortality and neonatal distress decreased in multiple pregnancies (p&#8201;&lt;&#8201;0.001 and p&#8201;=&#8201;0.003) and nullipara with breech pregnancies (p&#8201;&lt;&#8201;0.001 and p&#8201;=&#8201;0.024). Although not statistically significant, there was an increase in perinatal mortality (p&#8201;=&#8201;0.381) and neonatal distress (p&#8201;=&#8201;0.171) among multipara with single cephalic pregnancies in spontaneous labour. The maternal mortality ratio increased from 463/100, 000 live births in 2000 to 2002 to 650/100, 000 live births in 2009 to 2011 (p&#8201;=&#8201;0.031).
Conclusion:
The high CS rate among low-risk groups suggests that many CSs might have been performed on questionable indications. Such a trend may result in even higher CS rates in the future. While CS can improve perinatal outcomes, it does not necessarily do so if performed routinely in low-risk groups.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/107</link>
                <dc:creator>Helena Litorp</dc:creator>
                <dc:creator>Hussein Kidanto</dc:creator>
                <dc:creator>Lennarth Nystrom</dc:creator>
                <dc:creator>Elisabeth Darj</dc:creator>
                <dc:creator>Birgitta Essén</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:107</dc:source>
        <dc:date>2013-05-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-107</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-107-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>107</prism:startingPage>
        <prism:publicationDate>2013-05-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/106">
        <title>Fetal head circumference, operative delivery, and fetal outcomes: a multi-ethnic population-based cohort study</title>
        <description>Background:
Operative delivery procedures, such as primary cesarean section, vacuum-assisted, and forceps-assisted vaginal delivery increase maternal and fetal morbidity, and the cost of care. We evaluated whether large fetal head circumference (FHC) independently increases risk of such interventions, as well as fetal distress or low Apgar score, in anatomically normal infants.
Methods:
We conducted a population-based retrospective cohort study using Washington State birth certificate data. We included singleton, term infants born to nulliparous mothers from 2003&#8211;2009. We compared mode of delivery and fetal outcomes in 10,750 large-FHC (37-41&#160;cm) infants relative to 10,750 average-FHC (34&#160;cm) infants, frequency matched by birth-year.
Results:
Large-FHC infants were nearly twice as likely to be delivered by primary cesarean section as average-FHC infants (unadjusted relative risk [RR] 1.84, 95% confidence interval [CI]: 1.77, 1.92). The RR for primary cesarean section associated with large-FHC was largest for mothers aged 19&#160;years or less (RR 2.28; 95% CI: 1.99, 2.61), and smallest for mothers aged 35&#160;years or greater (RR 1.51; 95% CI: 1.37, 1.66) [test of homogeneity, p&#8201;&lt;&#8201;0.001]. Large-FHC infants were at increased risk of vacuum-assisted vaginal delivery (RR 1.55; 95% CI: 1.43, 1.69), and forceps-assisted vaginal delivery (RR 1.61; 95% CI: 1.32, 1.97). There was no difference in risk of fetal distress (RR 0.97; 95% CI: 0.89, 1.07) for large-FHC versus average-FHC infants. Risk estimates were unaffected by adjustment for potential confounders.
Conclusions:
Nulliparous mothers of large-FHC infants are at increased risk of primary cesarean section, vacuum-assisted and forceps-assisted vaginal delivery relative to mothers of average-FHC infants. Maternal age modifies the association between FHC and primary cesarean section.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/106</link>
                <dc:creator>Andrew Mujugira</dc:creator>
                <dc:creator>Alfred Osoti</dc:creator>
                <dc:creator>Ruth Deya</dc:creator>
                <dc:creator>Stephen Hawes</dc:creator>
                <dc:creator>Amanda Phipps</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:106</dc:source>
        <dc:date>2013-05-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-106</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-106-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>106</prism:startingPage>
        <prism:publicationDate>2013-05-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/13/105">
        <title>Impact on Caesarean section rates following injections of sterile water (ICARIS): a multicentre randomised controlled trial</title>
        <description>Background:
Sterile water injections have been used as an effective intervention for the management of back pain during labour. The objective of the current research is to determine if sterile water injections, as an intervention for back pain in labour, will reduce the intrapartum caesarean section rate.Methods/designDesign:
						 A double blind randomised placebo controlled trialSetting:
						 Maternity hospitals in AustraliaParticipants
						: 1866 women in labour, &#8805;18 years of age who have a singleton pregnancy with a fetus in a cephalic presentation at term (between 37 + 0 and 41 + 6 weeks gestation), who assess their back pain as equal to or greater than seven on a visual analogue scale when requesting analgesia and able to provide informed consent.Intervention:
						 Participants will be randomised to receive either 0.1 to 0.3 millilitres of sterile water or a normal saline placebo via four intradermal injections into four anatomical points surrounding the Michaelis&#8217; rhomboid over the sacral area. Two injections will be administered over the posterior superior iliac spine (PSIS) and the remaining two at two centimetres posterior, and one centimetre medial to the PSIS respectively.Main outcome measure:
						Proportion of women who have a caesarean section in labour.Randomisation:
						 Permuted blocks stratified by research site.Blinding (masking):
						Double-blind trial in which participants, clinicians and research staff blinded to group assignment.Funding:
						Funded by the National Health and Medical Research CouncilTrial registration:
						Australian New Zealand Clinical Trials Registry (No ACTRN12611000221954).DiscussionSterile water injections, which may have a positive effect on reducing the CS rate, have been shown to be a safe and simple analgesic suitable for most maternity settings. A procedure that could reduce intervention rates without adversely affecting safety for mother and baby would benefit Australian families and taxpayers and would reduce requirements for maternal operating theatre time. Results will have external validity, as the technique may be easily applied to maternity populations outside Australia. In summary, the results of this trial will contribute High level evidence on the impact of SWI on intrapartum CS rates and provide evidence of the analgesic effect of SWI on back pain.</description>
        <link>http://www.biomedcentral.com/1471-2393/13/105</link>
                <dc:creator>Nigel Lee</dc:creator>
                <dc:creator>Lena Mårtensson</dc:creator>
                <dc:creator>Caroline Homer</dc:creator>
                <dc:creator>Joan Webster</dc:creator>
                <dc:creator>Kristen Gibbons</dc:creator>
                <dc:creator>Helen Stapleton</dc:creator>
                <dc:creator>Natalie Dos Santos</dc:creator>
                <dc:creator>Michael Beckmann</dc:creator>
                <dc:creator>Yu Gao</dc:creator>
                <dc:creator>Sue Kildea</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2013, null:105</dc:source>
        <dc:date>2013-05-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-13-105</dc:identifier>
                                <prism:require>/content/figures/1471-2393-13-105-toc.gif</prism:require>
                <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>105</prism:startingPage>
        <prism:publicationDate>2013-05-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
